Corbus Pharmaceuticals Holdings Inc. (CRBP)

6.44
0.10 1.50
NASDAQ : Health Technology
Prev Close 6.54
Open 6.52
Day Low/High 6.38 / 6.52
52 Wk Low/High 4.50 / 9.11
Volume 122.69K
Avg Volume 811.80K
Exchange NASDAQ
Shares Outstanding 64.45M
Market Cap 426.05M
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

CRBP Crosses Above Key Moving Average Level

CRBP Crosses Above Key Moving Average Level

In trading on Monday, shares of Corbus Pharmaceuticals Holdings Inc crossed above their 200 day moving average of $6.99, changing hands as high as $7.13 per share. Corbus Pharmaceuticals Holdings Inc shares are currently trading up about 2% on the day.

Robbins Arroyo LLP: Corbus Pharmaceuticals Holdings, Inc. (CRBP) Sued For Misleading Shareholders

Robbins Arroyo LLP: Corbus Pharmaceuticals Holdings, Inc. (CRBP) Sued For Misleading Shareholders

Shareholder rights law firm Robbins Arroyo LLP reminds shareholders that purchasers of Corbus Pharmaceuticals Holdings, Inc.

CRBP Makes Notable Cross Below Critical Moving Average

CRBP Makes Notable Cross Below Critical Moving Average

In trading on Wednesday, shares of Corbus Pharmaceuticals Holdings Inc crossed below their 200 day moving average of $6.84, changing hands as low as $6.71 per share. Corbus Pharmaceuticals Holdings Inc shares are currently trading off about 4.4% on the day.

Ben & Jerry's Wants to Get in on CBD Craze

Ben & Jerry's Wants to Get in on CBD Craze

The company's announcement comes ahead of an FDA's public hearing on the legalization of CBD-infused foods and beverages on Friday.

First Week Of January 2020 Options Trading For Corbus Pharmaceuticals Holdings (CRBP)

First Week Of January 2020 Options Trading For Corbus Pharmaceuticals Holdings (CRBP)

Investors in Corbus Pharmaceuticals Holdings Inc saw new options begin trading this week, for the January 2020 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 232 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Corbus Pharmaceuticals Holdings, Inc.

There Is Generally Good Action on My Screens Today

There Is Generally Good Action on My Screens Today

The price action is quite good.

Robbins Arroyo LLP: Corbus Pharmaceutical Holdings, Inc. (CRBP) Sued For Misleading Shareholders

Robbins Arroyo LLP: Corbus Pharmaceutical Holdings, Inc. (CRBP) Sued For Misleading Shareholders

Shareholder rights law firm Robbins Arroyo LLP announces that purchasers of Corbus Pharmaceutical Holdings, Inc.

Glancy Prongay & Murray Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc.

Glancy Prongay & Murray Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc.

Glancy Prongay & Murray LLP ("GPM") reminds investors of the May 13, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Corbus Pharmaceuticals Holdings, Inc.

Glancy Prongay & Murray LLP Announces The Filing Of A Securities Class Action On Behalf Of Corbus Pharmaceuticals Holdings, Inc. Investors (CRBP)

Glancy Prongay & Murray LLP Announces The Filing Of A Securities Class Action On Behalf Of Corbus Pharmaceuticals Holdings, Inc. Investors (CRBP)

Glancy Prongay & Murray LLP ("GPM"), a national investors rights law firm, announces that a class action lawsuit has been filed on behalf of investors that acquired Corbus Pharmaceuticals Holdings, Inc.

Lifshitz & Miller LLP Announces Investigation Of Corbus Pharmaceutical Holdings, Inc., Domino's Pizza, Inc., Eventbrite, Inc., Healthcare Services Group, Inc., Maxar Technologies, Inc., And Micron Technology, Inc.

Lifshitz & Miller LLP Announces Investigation Of Corbus Pharmaceutical Holdings, Inc., Domino's Pizza, Inc., Eventbrite, Inc., Healthcare Services Group, Inc., Maxar Technologies, Inc., And Micron Technology, Inc.

NEW YORK, March 22, 2019 /PRNewswire/ -- Corbus Pharmaceutical Holdings, Inc. (CRBP) Lifshitz & Miller announces investigation into possible securities laws violations in connection with an article published by Seeking Alpha entitled, "Corbus Has Ties To...

CORBUS INVESTOR ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc.; Investors With Over $100K In Losses Are Encouraged To Contact The Firm - CRBP

CORBUS INVESTOR ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc.; Investors With Over $100K In Losses Are Encouraged To Contact The Firm - CRBP

NEW YORK, March 21, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Corbus Pharmaceuticals Holdings, Inc.

First Week Of May 17th Options Trading For Corbus Pharmaceuticals Holdings (CRBP)

First Week Of May 17th Options Trading For Corbus Pharmaceuticals Holdings (CRBP)

Investors in Corbus Pharmaceuticals Holdings Inc saw new options become available this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRBP options chain for the new May 17th contracts and identified the following call contract of particular interest.

Glancy Prongay & Murray LLP Announces Investigation On Behalf Of Corbus Pharmaceuticals Holdings, Inc. Investors

Glancy Prongay & Murray LLP Announces Investigation On Behalf Of Corbus Pharmaceuticals Holdings, Inc. Investors

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of Corbus Pharmaceuticals Holdings, Inc.

EQUITY ALERT: Rosen Law Firm Encourages Corbus Pharmaceuticals Holdings, Inc. Investors With Over $100K In Losses To Contact The Firm - CRBP

EQUITY ALERT: Rosen Law Firm Encourages Corbus Pharmaceuticals Holdings, Inc. Investors With Over $100K In Losses To Contact The Firm - CRBP

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Corbus Pharmaceuticals Holdings, Inc.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Corbus Pharmaceuticals Holdings, Inc. - CRBP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Corbus Pharmaceuticals Holdings, Inc. - CRBP

NEW YORK, March 13, 2019 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Corbus Pharmaceuticals Holdings, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. - CRBP

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. - CRBP

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Corbus Pharmaceuticals Holdings, Inc.

INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Corbus Pharmaceuticals Holdings, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Corbus Pharmaceuticals Holdings, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Corbus Pharmaceuticals Holdings, Inc.

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Corbus Pharmaceuticals Holdings, Inc. - CRBP

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Corbus Pharmaceuticals Holdings, Inc. - CRBP

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Corbus Pharmaceuticals Holdings, Inc.

Trading Notes for Select Stocks

Trading Notes for Select Stocks

Here's my take on a list of stocks I've been watching.

Tuesday's Rally Was Driven Mostly by Technical Conditions

Tuesday's Rally Was Driven Mostly by Technical Conditions

Market players didn't see it coming and that is what helped it gain so much strength.

It's a Stock Picker's Delight Right Now

It's a Stock Picker's Delight Right Now

With cash levels high, those players who are not well-positioned for upside action are scrambling to put money to work and are helping to propel prices higher.

First Week Of CRBP February 15th Options Trading

First Week Of CRBP February 15th Options Trading

Investors in Corbus Pharmaceuticals Holdings Inc saw new options become available this week, for the February 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRBP options chain for the new February 15th contracts and identified the following call contract of particular interest.

Corbus Pharmaceuticals Holdings Is Now Oversold (CRBP)

Corbus Pharmaceuticals Holdings Is Now Oversold (CRBP)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Corbus Pharmaceuticals Holdings Breaks Below 200-Day Moving Average - Notable For CRBP

Corbus Pharmaceuticals Holdings Breaks Below 200-Day Moving Average - Notable For CRBP

In trading on Tuesday, shares of Corbus Pharmaceuticals Holdings Inc crossed below their 200 day moving average of $6.11, changing hands as low as $5.95 per share. Corbus Pharmaceuticals Holdings Inc shares are currently trading off about 4.9% on the day.

Interesting CRBP Put And Call Options For July 2019

Interesting CRBP Put And Call Options For July 2019

Investors in Corbus Pharmaceuticals Holdings Inc saw new options become available this week, for the July 2019 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 232 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Corbus Pharmaceuticals Holdings Breaks Below 200-Day Moving Average - Notable For CRBP

Corbus Pharmaceuticals Holdings Breaks Below 200-Day Moving Average - Notable For CRBP

In trading on Wednesday, shares of Corbus Pharmaceuticals Holdings Inc crossed below their 200 day moving average of $6.21, changing hands as low as $6.01 per share. Corbus Pharmaceuticals Holdings Inc shares are currently trading down about 4.2% on the day.

First Week Of CRBP December 21st Options Trading

First Week Of CRBP December 21st Options Trading

Investors in Corbus Pharmaceuticals Holdings Inc saw new options begin trading this week, for the December 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRBP options chain for the new December 21st contracts and identified one put and one call contract of particular interest.

TheStreet Quant Rating: D (Sell)